Current Alzheimer Research

Editor-in-Chief

Prof. Debomoy K. Lahiri
(16607 citations)
Neuroscience Research Center
Indianapolis, IN 46202
(USA)

Nobel Laureates on Editorial Board

Prof. Jean-Marie Lehn
(France)

Prof. Ferid Murad
(USA)

Back

Become EABM
Become Reviewer

Editorial [ Drug Discovery for Alzheimers Disease: Filling the Pipeline Guest Editors: Antony R. Horton and Howard M. Fillit ] promotion: free to download

Volume:4   Issue: 5
Pp: 501-502
Antony R. Horton and Howard M. Fillit
DOI: 10.2174/156720507783018172

Small Molecule Neurotrophin Receptor Ligands: Novel Strategies for Targeting Alzheimers Disease Mechanisms

Volume:4   Issue: 5
Pp: 503-506
Frank M. Longo, Tao Yang, Juliet K. Knowles, Youmei Xie, Laura A. Moore and Stephen M. Massa
DOI: 10.2174/156720507783018316

Regeneration in a Degenerating Brain: Potential of Allopregnanolone as a Neuroregenerative Agent

Volume:4   Issue: 5
Pp: 510-517
Jun Ming Wang, Ronald W. Irwin, Lifei Liu, Shuhua Chen and Roberta Diaz Brinton
DOI: 10.2174/156720507783018262

Oligomers of β-Amyloid Peptide Inhibit BDNF-Induced Arc Expression in Cultured Cortical Neurons

Volume:4   Issue: 5
Pp: 518-521
Valentine Echeverria, Diego E. Berman and Ottavio Arancio
DOI: 10.2174/156720507783018190

Novel Multifunctional Anti-Alzheimer Drugs with Various CNS Neurotransmitter Targets and Neuroprotective Moieties

Volume:4   Issue: 5
Pp: 522-536
Cornelis J. Van der Schyf, Silvia Mandel, Werner J. Geldenhuys, Tamar Amit, Yael Avramovich, Hailin Zheng, Mati Fridkin, Shunit Gal, Orly Weinreb, Orit Bar Am, Yotam Sagi and Moussa B.H. Youdim
DOI: 10.2174/156720507783018226

Detrimental Effects of Apolipoprotein E4: Potential Therapeutic Targets in Alzheimers Disease

Volume:4   Issue: 5
Pp: 537-540
Robert W. Mahley, Yadong Huang and Karl H. Weisgraber
DOI: 10.2174/156720507783018334

APP-Based Neuroprotective Strategies

Volume:4   Issue: 5
Pp: 541-543
Dale E. Bredesen and Shahrooz Rabizadeh
DOI: 10.2174/156720507783018253

Inhibition of Tau Aggregation in Cell Models of Tauopathy

Volume:4   Issue: 5
Pp: 544-546
Inna Khlistunova, Marcus Pickhardt, Jacek Biernat, Yipeng Wang, Eva-Maria Mandelkow and Eckhard Mandelkow
DOI: 10.2174/156720507783018307

New Approaches to the Discovery of cdk5 Inhibitors

Volume:4   Issue: 5
Pp: 547-549
Marcie A. Glicksman, Gregory D. Cuny, Min Liu, Brittany Dobson, Kenneth Auerbach, Ross L. Stein and Kenneth S. Kosik
DOI: 10.2174/156720507783018181

Perispinal Etanercept for Treatment of Alzheimers Disease

Volume:4   Issue: 5
Pp: 550-552
Edward Tobinick
DOI: 10.2174/156720507783018217

Is Alpha-Synuclein Pathology a Target for Treatment of Neurodegenerative Disorders?

Volume:4   Issue: 5
Pp: 556-561
Manfred Windisch, Hans-Jorg Wolf, Birgit Hutter-Paier and Robert Wronski
DOI: 10.2174/156720507783018343

Discovery of ADDL-Targeting Small Molecule Drugs for Alzheimers Disease

Volume:4   Issue: 5
Pp: 562-567
Gary C. Look, Jasna Jerecic, Diana B. Cherbavaz, Todd R. Pray, Jean-Claude R. Breach, Walter J. Crosier, Lev Igoudin, Catherine M. Hironaka, Raymond M. Lowe, Michele McEntee, Lily Ruslim-Litrus, Hsiu-Mei Wu, Sue Zhang, Susan M. Catalano, William F. Goure, David Summa and Grant A. Krafft
DOI: 10.2174/156720507783018271

γ-Secretase Modulators

Volume:4   Issue: 5
Pp: 571-573
Michael S. Wolfe
DOI: 10.2174/156720507783018299

A New Model for Academics Based Drug Discovery

Volume:4   Issue: 5
Pp: 574-576
Ross L. Stein
DOI: 10.2174/156720507783018280

Cytotoxicity of Aβ 1-42, RAGE23-54, and An Aβ -RAGE Complex in PC-12 Cells

Volume:4   Issue: 5
Pp: 581-586
Shyamala Mruthinti, Nicholas Capito, Ajay Sood and Jerry J. Buccafusco
DOI: 10.2174/156720507783018325